FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911399879> ?p ?o ?g. }

• W2911399879 abstract "Overall survival of pediatric B-precursor ALL patients reached 90% in recent years. However, the outcome for refractory or relapsed children remains very poor. Anti-CD19 chimeric antigen receptor T-cells (CD19-CAR) showed significant antileukemic activity in relapsed and refractory B-precursor ALL. Especially in children, isolation of a suitable T-cell amount for autologous CAR T-cell manufacturing can be challenging due to low blood volume, low T-cell counts and clinical condition. In this case, the adoptive transfer of CAR T-cells from an unmatched healthy third-party donor provides a promising strategy. In order to prevent life-threatening graft-versus-host disease, a knockout (KO) of the endogenous T-cell receptor (TCR) has to be performed. Here, we generated CD19-CARs with a CRISPR/Cas9 mediated TCR KO, which remain highly functional and show strongly reduced alloreactivity compared to conventional CAR T-cells introduced into third-party T-cells. T-cells were isolated from peripheral blood mononuclear cells (PBMCs) of healthy donors and activated via anti-CD3/anti-CD28 stimulation. Retroviral transduction of a second generation anti-CD19 CAR (containing CD3zeta and 4-1BB stimulatory domains) was performed, followed by CRISPR/Cas9 mediated KO of the T-cell receptor beta chain via electroporation. After eleven days of expansion in the presence of IL-7 and IL-15, cells were purified for TCR KO-CD19-CAR T-cells via magnetic separation. Finally, the cell product was analyzed for cellular characteristics, functionality and alloreactivity by flow cytometry. A mean transduction rate of 37% for CD19-CARs and 40% for TCR KO-CD19-CARs was reached as well as a mean TCR KO rate of 78%. Both CD19-CARs as well as TCR KO-CD19-CARs showed suitable amounts of CD4- (45% vs. 33%) and CD8-T-cells (37% vs. 48%). The phenotype of CD19-CARs and TCR KO-CD19-CARs were comparable with mainly central memory (CM) (38% vs. 40%) and effector memory (EM) (57% vs. 51%) T-cells. The expansion of TCR KO-CD19-CARs was significantly reduced compared to conventional CD19-CARs (54-fold vs. 109-fold). This effect was not mediated by the loss of the TCR, but due to electroporation procedure. While CD19-CARs with or without TCR KO showed almost no background expression of the activation marker CD25 (2% vs 1%), contact with CD19-expressing targeT-cells resulted in a comparable upregulation of CD25 in both groups (95% vs. 94%). Co-culture with a CD19-expressing targeT-cell line led to an increased Interferon-γ secretion compared to unstimulated CARs, which was not significantly altered by the TCR KO (17% CD19-CAR vs. 14% TCR KO-CD19-CAR). CD19-dependent proliferative capacity of CAR T-cells was not influenced by loss of the TCR, as in both cases 97% of the T-cells proliferated after antigen recognition. Both CD19-CARs as well as TCR KO-CD19-CARs showed high, antigen-specific killing of 86% vs. 87% of the CD19-expressing targeT-cells at a 1:1 effector to target ratio. To evaluate the alloreactive potential of those T-cells, T-cells were co-cultured with irradiated PBMCs pooled from six different donors. 20% of TCR-expressing T-cells showed proliferation upon contact with non-HLA-matched PBMCs, whereas T-cells with a TCR KO showed almost no proliferation ( Citation Format: Dana Stenger, Tanja Stief, Theresa Kauferle, Semjon Manuel Willier, Felicitas Rataj, Kilian Schober, Ramin Lotfi, Beate Wagner, Dirk H. Busch, Sebastian Kobold, Franziska Blaeschke, Tobias Feuchtinger. Anti-CD19 CAR T-cells with a CRISPR/Cas9-mediated T-cell receptor knockout show high functionality in the absence of alloreactivity in vitro [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr A043." @default.
• W2911399879 created "2019-02-21" @default.
• W2911399879 creator A5002329046 @default.
• W2911399879 creator A5013500913 @default.
• W2911399879 creator A5020207883 @default.
• W2911399879 creator A5050281853 @default.
• W2911399879 creator A5059831431 @default.
• W2911399879 creator A5062895290 @default.
• W2911399879 creator A5063112962 @default.
• W2911399879 creator A5064628032 @default.
• W2911399879 creator A5071868326 @default.
• W2911399879 creator A5084382516 @default.
• W2911399879 creator A5085199943 @default.
• W2911399879 creator A5089589180 @default.
• W2911399879 date "2019-02-01" @default.
• W2911399879 modified "2023-09-26" @default.
• W2911399879 title "Abstract A043: Anti-CD19 CAR T-cells with a CRISPR/Cas9-mediated T-cell receptor knockout show high functionality in the absence of alloreactivity in vitro" @default.
• W2911399879 doi "https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a043" @default.
• W2911399879 hasPublicationYear "2019" @default.
• W2911399879 type Work @default.
• W2911399879 sameAs 2911399879 @default.
• W2911399879 citedByCount "0" @default.
• W2911399879 crossrefType "proceedings-article" @default.
• W2911399879 hasAuthorship W2911399879A5002329046 @default.
• W2911399879 hasAuthorship W2911399879A5013500913 @default.
• W2911399879 hasAuthorship W2911399879A5020207883 @default.
• W2911399879 hasAuthorship W2911399879A5050281853 @default.
• W2911399879 hasAuthorship W2911399879A5059831431 @default.
• W2911399879 hasAuthorship W2911399879A5062895290 @default.
• W2911399879 hasAuthorship W2911399879A5063112962 @default.
• W2911399879 hasAuthorship W2911399879A5064628032 @default.
• W2911399879 hasAuthorship W2911399879A5071868326 @default.
• W2911399879 hasAuthorship W2911399879A5084382516 @default.
• W2911399879 hasAuthorship W2911399879A5085199943 @default.
• W2911399879 hasAuthorship W2911399879A5089589180 @default.
• W2911399879 hasConcept C10882517 @default.
• W2911399879 hasConcept C137061746 @default.
• W2911399879 hasConcept C147483822 @default.
• W2911399879 hasConcept C148125776 @default.
• W2911399879 hasConcept C153911025 @default.
• W2911399879 hasConcept C167672396 @default.
• W2911399879 hasConcept C185592680 @default.
• W2911399879 hasConcept C19317047 @default.
• W2911399879 hasConcept C202751555 @default.
• W2911399879 hasConcept C203014093 @default.
• W2911399879 hasConcept C2776090121 @default.
• W2911399879 hasConcept C2778957590 @default.
• W2911399879 hasConcept C28328180 @default.
• W2911399879 hasConcept C3875195 @default.
• W2911399879 hasConcept C55493867 @default.
• W2911399879 hasConcept C86803240 @default.
• W2911399879 hasConcept C8891405 @default.
• W2911399879 hasConcept C90375314 @default.
• W2911399879 hasConcept C95444343 @default.
• W2911399879 hasConceptScore W2911399879C10882517 @default.
• W2911399879 hasConceptScore W2911399879C137061746 @default.
• W2911399879 hasConceptScore W2911399879C147483822 @default.
• W2911399879 hasConceptScore W2911399879C148125776 @default.
• W2911399879 hasConceptScore W2911399879C153911025 @default.
• W2911399879 hasConceptScore W2911399879C167672396 @default.
• W2911399879 hasConceptScore W2911399879C185592680 @default.
• W2911399879 hasConceptScore W2911399879C19317047 @default.
• W2911399879 hasConceptScore W2911399879C202751555 @default.
• W2911399879 hasConceptScore W2911399879C203014093 @default.
• W2911399879 hasConceptScore W2911399879C2776090121 @default.
• W2911399879 hasConceptScore W2911399879C2778957590 @default.
• W2911399879 hasConceptScore W2911399879C28328180 @default.
• W2911399879 hasConceptScore W2911399879C3875195 @default.
• W2911399879 hasConceptScore W2911399879C55493867 @default.
• W2911399879 hasConceptScore W2911399879C86803240 @default.
• W2911399879 hasConceptScore W2911399879C8891405 @default.
• W2911399879 hasConceptScore W2911399879C90375314 @default.
• W2911399879 hasConceptScore W2911399879C95444343 @default.
• W2911399879 hasLocation W29113998791 @default.
• W2911399879 hasOpenAccess W2911399879 @default.
• W2911399879 hasPrimaryLocation W29113998791 @default.
• W2911399879 hasRelatedWork W1489655296 @default.
• W2911399879 hasRelatedWork W1876602139 @default.
• W2911399879 hasRelatedWork W1942198241 @default.
• W2911399879 hasRelatedWork W2011177769 @default.
• W2911399879 hasRelatedWork W2012687633 @default.
• W2911399879 hasRelatedWork W2099784945 @default.
• W2911399879 hasRelatedWork W2363351404 @default.
• W2911399879 hasRelatedWork W2564245888 @default.
• W2911399879 hasRelatedWork W2788710496 @default.
• W2911399879 hasRelatedWork W2902644415 @default.
• W2911399879 hasRelatedWork W2954311642 @default.
• W2911399879 hasRelatedWork W2954843180 @default.
• W2911399879 hasRelatedWork W2979585453 @default.
• W2911399879 hasRelatedWork W2990546485 @default.
• W2911399879 hasRelatedWork W3006614976 @default.
• W2911399879 hasRelatedWork W3026009801 @default.
• W2911399879 hasRelatedWork W3104499934 @default.
• W2911399879 hasRelatedWork W3159623678 @default.
• W2911399879 hasRelatedWork W3198267515 @default.
• W2911399879 hasRelatedWork W2289554817 @default.
• W2911399879 isParatext "false" @default.
• W2911399879 isRetracted "false" @default.
• W2911399879 magId "2911399879" @default.
• W2911399879 workType "article" @default.